GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » Other Operating Expense

MDxHealth (MDxHealth) Other Operating Expense : $3.36 Mil (TTM As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is MDxHealth Other Operating Expense?

MDxHealth's Other Operating Expense for the three months ended in Sep. 2023 was $-0.01 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 was $3.36 Mil.

MDxHealth's quarterly Other Operating Expense declined from Mar. 2023 ($0.72 Mil) to Jun. 2023 ($-0.06 Mil) but then increased from Jun. 2023 ($-0.06 Mil) to Sep. 2023 ($-0.01 Mil).

MDxHealth's annual Other Operating Expense declined from Dec. 2020 ($2.13 Mil) to Dec. 2021 ($0.69 Mil) but then increased from Dec. 2021 ($0.69 Mil) to Dec. 2022 ($2.55 Mil).


MDxHealth Other Operating Expense Historical Data

The historical data trend for MDxHealth's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MDxHealth Other Operating Expense Chart

MDxHealth Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 3.33 2.13 0.69 2.55

MDxHealth Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 2.71 0.72 -0.06 -0.01

MDxHealth Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MDxHealth Other Operating Expense Related Terms

Thank you for viewing the detailed overview of MDxHealth's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


MDxHealth (MDxHealth) Business Description

Traded in Other Exchanges
N/A
Address
Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.